BCTX Stock Analysis: Buy, Sell, or Hold?
BCTX - Briacell Therapeutics Corp. Common Shares
$4.30
-0.01 (-0.23%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 11, 2026
Get Alerted When BCTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called BCTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BCTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: BCTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: BCTX is currently trading at $4.30, which is considered slightly low relative to its 30-day fair value range of $4.69 to $8.28.
Technical Outlook: Technically, BCTX is in a downtrend. Immediate support is located at $4.10, while resistance sits at $5.16.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $150.00 (+3380.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BCTX is in a downtrend. Immediate support is located at $4.10, while resistance sits at $5.16.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $150.00 (+3380.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$4.69 -
$8.28
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 3380.3% below Wall St target ($150.00)
Fair Price Analysis
30-Day Fair Range
$4.69 -
$8.28
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.10
Resistance Level
$5.16
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.27
Wall Street Target
$150.00
(+3380.3%)
Last updated: January 31, 2026 11:43 AM ET
Data refreshes hourly during market hours. Next update: 12:43 PM
Data refreshes hourly during market hours. Next update: 12:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced BCTX Option Strategies
Professional options setups generated by AI based on today's BCTX price and gamma walls.
